| scholarly article | Q13442814 |
| P2093 | author name string | Lawrence Banks | |
| Paola Massimi | |||
| Gary S Shaw | |||
| Joe S Mymryk | |||
| Katherine Hung | |||
| Frederick A Dick | |||
| Biljana Todorovic | |||
| Nikita Avvakumov | |||
| P2860 | cites work | Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor | Q36098917 |
| A point mutational analysis of human papillomavirus type 16 E7 protein | Q36828310 | ||
| The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein | Q36888103 | ||
| Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product | Q37016112 | ||
| Rapid induction of senescence in human cervical carcinoma cells | Q37268828 | ||
| pRb, a local chromatin organizer with global possibilities | Q37588543 | ||
| Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines | Q37838646 | ||
| Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein | Q38310322 | ||
| Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest | Q39602729 | ||
| Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. | Q39606496 | ||
| The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity | Q39633445 | ||
| HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background | Q40068344 | ||
| The adenovirus E4orf6 E3 ubiquitin ligase complex assembles in a novel fashion | Q40157700 | ||
| pRB Contains an E2F1-Specific Binding Domain that Allows E2F1-Induced Apoptosis to Be Regulated Separately from Other E2F Activities | Q40629059 | ||
| Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis | Q41071971 | ||
| E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. | Q41158814 | ||
| Transcription of human papillomavirus type-18 DNA in human cervical carcinoma cell lines | Q44914495 | ||
| Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. | Q45417338 | ||
| Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas | Q70175894 | ||
| An integral membrane green fluorescent protein marker, Us9-GFP, is quantitatively retained in cells during propidium iodide-based cell cycle analysis by flow cytometry | Q74644944 | ||
| The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein | Q82810796 | ||
| Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins | Q22253968 | ||
| Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor | Q24292803 | ||
| Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7 | Q24296551 | ||
| The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation | Q24300757 | ||
| Interaction of the HPV E7 proteins with the pCAF acetyltransferase | Q24305508 | ||
| Cyclin-binding motifs are essential for the function of p21CIP1 | Q24316125 | ||
| Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure | Q28131658 | ||
| Retinoblastoma protein recruits histone deacetylase to repress transcription | Q28262144 | ||
| The regulation of E2F by pRB-family proteins | Q28278789 | ||
| FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP) | Q28283721 | ||
| Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions | Q28301685 | ||
| The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product | Q29618372 | ||
| E2F: a link between the Rb tumor suppressor protein and viral oncoproteins | Q29618375 | ||
| Classification of papillomaviruses | Q29618731 | ||
| Evidence for a causal association between human papillomavirus and a subset of head and neck cancers | Q33180284 | ||
| The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome | Q33292204 | ||
| The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth | Q33292242 | ||
| Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes | Q33844017 | ||
| Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. | Q33929053 | ||
| Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein | Q33932831 | ||
| The Pezcoller lecture: cancer cell cycles revisited | Q33987290 | ||
| Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. | Q34122679 | ||
| The retinoblastoma tumour suppressor in development and cancer | Q34161991 | ||
| Retinoblastoma protein partners | Q34305195 | ||
| Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein | Q34742793 | ||
| Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases | Q34799489 | ||
| The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. | Q35192986 | ||
| Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation | Q35382611 | ||
| Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways | Q35815917 | ||
| Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells | Q35838905 | ||
| Human papillomavirus vaccines launch a new era in cervical cancer prevention | Q35944623 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | retinoblastoma | Q500695 |
| human papillomavirus 16 | Q69461345 | ||
| P304 | page(s) | 13313-13323 | |
| P577 | publication date | 2012-09-26 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor | |
| P478 | volume | 86 |
| Q42173312 | Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome |
| Q92937016 | Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis |
| Q38687133 | BK Polyomavirus Infection and Renourinary Tumorigenesis |
| Q37327810 | CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis |
| Q38789833 | ERK Signaling Pathway Is Involved in HPV-16 E6 but not E7 Oncoprotein-Induced HIF-1α Protein Accumulation in NSCLC Cells |
| Q91993564 | HPV 16 E6/E7 up-regulate the expression of both HIF-1α and GLUT1 by inhibition of RRAD and activation of NF-κB in lung cancer cells |
| Q47549187 | Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-dependent Protein Degradation |
| Q99566902 | Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7 |
| Q92869077 | Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells |
| Q38859115 | Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes. |
| Q38911301 | Levels of the E2 interacting protein TopBP1 modulate papillomavirus maintenance stage replication |
| Q38719253 | Monitoring HPV-16 E7 phosphorylation events |
| Q64256422 | Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology |
| Q91673583 | New insights into Sauropsid Papillomaviridae evolution and epizootiology: discovery of two novel papillomaviruses in native and invasive Island geckos |
| Q36952911 | Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes |
| Q21090587 | Polyomavirus-associated Trichodysplasia spinulosa involves hyperproliferation, pRB phosphorylation and upregulation of p16 and p21 |
| Q39258251 | Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins |
| Q64992613 | Regulating the human HECT E3 ligases. |
| Q95840169 | Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7 |
| Q30277065 | The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. |
| Q42277084 | The heterogeneous structural behavior of E7 from HPV16 revealed by NMR spectroscopy |
| Q39000409 | The human papillomavirus E7 oncoprotein as a regulator of transcription |
| Q30410482 | The human papillomavirus E7 proteins associate with p190RhoGAP and alter its function |
| Q37198662 | The papillomavirus E7 proteins |
| Q38249250 | miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas |
Search more.